Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wald

Showing results (111-120 of 550) with videos related to

Pageof 55
Sort By:
BMJ (Clinical Research Ed.)|November 11, 1995
Misleading meta-analysis. One incorrect meta-analysis does not invalidate them allM R Law, N J Wald
British Journal of Obstetrics and Gynaecology|July 1, 1982
Evidence against oral contraceptives as a cause of neural-tube defectsH S Cuckle, N J Wald
Journal of Medical Screening|April 18, 2015
Performance of antenatal reflex DNA screening for Down's syndromeNicholas J Wald, Jonathan P Bestwick
Prenatal Diagnosis|June 29, 2012
The estimation of gestational age of pregnancy for use in screening for Down syndrome using ultrasound measurements and embryo transfer dateWayne J Huttly, Nicholas J Wald
Prenatal Diagnosis|September 22, 1998
Alternative methods of maternal weight adjustment in maternal serum screening for Down syndrome and neural tube defectsH C Watt, N J Wald
Journal of Medical Screening|March 17, 2007
Estimating the risk of Down's syndrome in antenatal screening and the gestation at which this risk appliesJ K Morris, N J Wald
European Journal of Epidemiology|May 28, 2015
Erratum to: Quantifying the health benefits of chronic disease prevention: a fresh approach using cardiovascular disease as an exampleNicholas J Wald, Joan K Morris
Lancet (London, England)|November 28, 2021
Mandatory UK folic acid fortificationNicholas J Wald, A Victor Hoffbrand
Journal of Medical Screening|February 29, 2000
Quantifying the decline in the birth prevalence of neural tube defects in England and WalesJ K Morris, N J Wald
Journal of Medical Screening|February 29, 2000
The target plot: a new way of displaying the performance of a screening testN J Wald, H C Watt
Pageof 55

Showing results (111-120 of 550) with videos related to

Sort By:
Pageof 55
BMJ (Clinical Research Ed.)|November 11, 1995
Misleading meta-analysis. One incorrect meta-analysis does not invalidate them allM R Law, N J Wald
British Journal of Obstetrics and Gynaecology|July 1, 1982
Evidence against oral contraceptives as a cause of neural-tube defectsH S Cuckle, N J Wald
Journal of Medical Screening|April 18, 2015
Performance of antenatal reflex DNA screening for Down's syndromeNicholas J Wald, Jonathan P Bestwick
Prenatal Diagnosis|June 29, 2012
The estimation of gestational age of pregnancy for use in screening for Down syndrome using ultrasound measurements and embryo transfer dateWayne J Huttly, Nicholas J Wald
Prenatal Diagnosis|September 22, 1998
Alternative methods of maternal weight adjustment in maternal serum screening for Down syndrome and neural tube defectsH C Watt, N J Wald
Journal of Medical Screening|March 17, 2007
Estimating the risk of Down's syndrome in antenatal screening and the gestation at which this risk appliesJ K Morris, N J Wald
European Journal of Epidemiology|May 28, 2015
Erratum to: Quantifying the health benefits of chronic disease prevention: a fresh approach using cardiovascular disease as an exampleNicholas J Wald, Joan K Morris
Lancet (London, England)|November 28, 2021
Mandatory UK folic acid fortificationNicholas J Wald, A Victor Hoffbrand
Journal of Medical Screening|February 29, 2000
Quantifying the decline in the birth prevalence of neural tube defects in England and WalesJ K Morris, N J Wald
Journal of Medical Screening|February 29, 2000
The target plot: a new way of displaying the performance of a screening testN J Wald, H C Watt
Pageof 55